Aditya Birla Sun Life Pharma and Healthcare Fund vs Nippon India Pharma Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth
Chart Comparison
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹7404 Cr | ₹704 Cr |
| Min Investment | ₹5000 | ₹1000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 01 Jun 2004 | 05 Jul 2019 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare |
| Turn Over | 21% | 31% |
| Expense Ratio | 1.82 | 2.37 |
| Manager | Sailesh Raj Bhan | Dhaval Joshi |
| ISIN Code | INF204K01968 | INF209KB1N91 |
| Exits Load | Exit load of 1% if redeemed within 1 month./365 | Exit load of 1% if redeemed within 30 days./365 |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| 1 Month | 6.25% | 5.81% |
| 6 Month | 19.11% | 18.62% |
| 1 Year | 47.43% | 52.25% |
| 3 Year | 18.54% | 17.32% |
| 5 Year | 30.13% | 25.87% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 17.1% | 17.07% |
| 3 Year | 43.51% | 41.28% |
| 5 Year | 81.66% | 69.6% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| 1 Year | 26.16% | 22.24% |
| 3 Year | 53.8% | 45.6% |
| 5 Year | 80.65% | 68.38% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Standard Deviation | 14.36% | 14.83% |
| Sharp | 0.68% | 0.61% |
| Beta | 0.91% | 0.96% |
| Alpha | 1.57% | 0.67% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Name | Sailesh Raj Bhan | Dhaval Joshi |
| Total AUM | ₹96086 Cr | ₹361932 Cr |
| Fund Manage | 5 | 55 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Large Cap | 41.85 | 41.66 |
| Mid Cap | 35.52 | 36.37 |
| Small Cap | 20.97 | 18.68 |
| Others | 1.66 | 3.28 |
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Healthcare | 98.34 | 93.86 |
| Others | 1.66 | 2.25 |
| Insurance | - | 1.86 |
| Services | - | 1.03 |
| Chemicals | - | 0.99 |
Top Comparisons
ICICI Prudential ELSS Tax Saver Fund (Tax Saving) - Growth
3Y Returns16.95%
Sundaram ELSS Tax Saver Fund Regular Growth
3Y Returns16.61%
UTI Medium Duration Fund - Regular Plan - Growth Option
3Y Returns6.03%
SUNDARAM MEDIUM DURATION FUND Regular Plan - Growth
3Y Returns3.6%
Kotak Multi Asset Allocation Fund - Regular (G)
3Y Returns0%
UTI Multi Asset Allocation Fund - Regular Plan - Growth Option
3Y Returns17.97%
Franklin India Corporate Debt Fund - Growth
3Y Returns5.23%
Axis Corporate Debt Fund - Regular Plan Growth
3Y Returns5.65%